ReviewBrain, behavior, & immunity - health2024

Viewpoints Sigma-1 receptor agonist fluvoxamine for multiple sclerosis.

Kenji HashimotoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.